Foreign Drug Inspections Would Be Funded By Registration Fees In Draft U.S. Bill

U.S. FDA inspections of overseas drug producers would be supported by annual registration fees under a legislative "discussion draft" being circulated by House Energy and Commerce Committee Chairman John Dingell, D-Mich.